LMR Partners LLP - INTELLIA THERAPEUTICS INC ownership

INTELLIA THERAPEUTICS INC's ticker is NTLA and the CUSIP is 45826J105. A total of 300 filers reported holding INTELLIA THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is 0.55 and the average weighting 0.1%.

Quarter-by-quarter ownership
LMR Partners LLP ownership history of INTELLIA THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$957,770
+25.7%
30,290
+62.1%
0.01%
+37.5%
Q2 2023$762,178
+65.6%
18,690
+41.7%
0.01%0.0%
Q4 2022$460,269
-65.7%
13,192
-45.1%
0.01%
-68.0%
Q3 2022$1,343,000
+83.2%
24,008
+69.6%
0.02%
+108.3%
Q2 2022$733,000
-42.9%
14,152
-19.8%
0.01%
-20.0%
Q1 2022$1,283,00017,6490.02%
Other shareholders
INTELLIA THERAPEUTICS INC shareholders Q4 2022
NameSharesValueWeighting ↓
Atlas Venture Associates IX, LLC 1,113,376$89,359,00015.01%
Burrage Capital Management LLC 63,634$5,107,0004.14%
Integral Health Asset Management, LLC 170,000$13,643,0003.90%
Ally Bridge Group (NY) LLC 225,000$18,057,0003.46%
Elmwood Wealth Management, Inc. 67,174$5,391,0003.29%
Nikko Asset Management Americas, Inc. 4,843,270$388,697,0001.90%
ARK Investment Management 9,611,911$771,404,0001.53%
Spectrum Planning & Advisory Services Inc. 18,521$1,486,0001.53%
Lombard Odier Asset Management (Switzerland) SA 282,953$22,708,0001.51%
Intellectus Partners, LLC 71,625$4,606,0001.26%
View complete list of INTELLIA THERAPEUTICS INC shareholders